FI841153A0 - Med kromon och tiokromon substituerade 1,4-dihydropyridonlaktoner, flera foerfaranden foer framstaellning av dessa och deras anvaendning i laekemedel. - Google Patents

Med kromon och tiokromon substituerade 1,4-dihydropyridonlaktoner, flera foerfaranden foer framstaellning av dessa och deras anvaendning i laekemedel.

Info

Publication number
FI841153A0
FI841153A0 FI841153A FI841153A FI841153A0 FI 841153 A0 FI841153 A0 FI 841153A0 FI 841153 A FI841153 A FI 841153A FI 841153 A FI841153 A FI 841153A FI 841153 A0 FI841153 A0 FI 841153A0
Authority
FI
Finland
Prior art keywords
dihydropyridonlactoner
thiochromone
foerfaranden
laekemedel
chromon
Prior art date
Application number
FI841153A
Other languages
English (en)
Other versions
FI81100B (fi
FI81100C (fi
FI841153A (fi
Inventor
Siegfried Goldmann
Friedrich Bossert
Matthias Schramm
Guenter Thomas
Rainer Gross
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of FI841153A0 publication Critical patent/FI841153A0/fi
Publication of FI841153A publication Critical patent/FI841153A/fi
Publication of FI81100B publication Critical patent/FI81100B/fi
Application granted granted Critical
Publication of FI81100C publication Critical patent/FI81100C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/02Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/66Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/0803Compounds with Si-C or Si-Si linkages
    • C07F7/081Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
    • C07F7/0812Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Steroid Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI841153A 1983-03-25 1984-03-22 Foerfarande foer framstaellning av terapeutiskt aktiva 1,4,5,7-tetrahydrofuro/3,4-b/pyridinderivat. FI81100C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19833311003 DE3311003A1 (de) 1983-03-25 1983-03-25 Chromon- und thiochromonsubstituierte 1,4-dihydropyridinlactone, mehrere verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
DE3311003 1983-03-25

Publications (4)

Publication Number Publication Date
FI841153A0 true FI841153A0 (fi) 1984-03-22
FI841153A FI841153A (fi) 1984-09-26
FI81100B FI81100B (fi) 1990-05-31
FI81100C FI81100C (fi) 1990-09-10

Family

ID=6194710

Family Applications (1)

Application Number Title Priority Date Filing Date
FI841153A FI81100C (fi) 1983-03-25 1984-03-22 Foerfarande foer framstaellning av terapeutiskt aktiva 1,4,5,7-tetrahydrofuro/3,4-b/pyridinderivat.

Country Status (20)

Country Link
US (1) US4555512A (fi)
EP (1) EP0123095B1 (fi)
JP (1) JPS59193887A (fi)
KR (1) KR920001137B1 (fi)
AT (1) ATE38229T1 (fi)
AU (1) AU564838B2 (fi)
CA (1) CA1211109A (fi)
DE (2) DE3311003A1 (fi)
DK (1) DK158950C (fi)
ES (5) ES8607307A1 (fi)
FI (1) FI81100C (fi)
GR (1) GR81924B (fi)
HU (1) HU189849B (fi)
IE (1) IE57039B1 (fi)
IL (1) IL71314A (fi)
NO (1) NO160659C (fi)
NZ (1) NZ207588A (fi)
PH (1) PH20322A (fi)
PT (1) PT78311B (fi)
ZA (1) ZA842166B (fi)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4011105A1 (de) * 1990-04-06 1991-10-10 Bayer Ag Neue 4-chinolyl-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
US5204472A (en) * 1990-04-06 1993-04-20 Bayer Aktiengesellschaft Quinoline and isoquinoline intermediates
DE4313696A1 (de) * 1993-04-27 1994-11-03 Bayer Ag 2-Amino-4-heteroaryl-1,4-dihydropyridine, Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimitteln
AU2004272078A1 (en) * 2003-09-10 2005-03-24 Synta Pharmaceuticals Corp. Dihydropyridine compounds for treating or preventing metabolic disorders
DE102005034264A1 (de) 2005-07-22 2007-02-01 Bayer Healthcare Ag 4-Chromenonyl-1,4-dihydropyridincarbonitrile und ihre Verwendung
DE102005034267A1 (de) 2005-07-22 2007-01-25 Bayer Healthcare Ag 4-Chromenonyl-1,4-dihydropyridine und ihre Verwendung
EP2039678A1 (de) 2007-09-18 2009-03-25 Bayer CropScience AG Verfahren zum Herstellen von 4-Aminobut-2-enoliden
EP2042496A1 (de) 2007-09-18 2009-04-01 Bayer CropScience AG Verfahren zur Herstellung von 4-Aminobut-2-enoliden
EP2230236A1 (de) 2009-03-16 2010-09-22 Bayer CropScience AG Neues Verfahren zur Herstellung von Enaminocarbonyl-Verbindungen
EP2230237A1 (de) 2009-03-16 2010-09-22 Bayer CropScience AG Neues Verfahren zur Herstellung von Enaminocarbonyl-Verbindungen
TW201111370A (en) 2009-08-18 2011-04-01 Bayer Cropscience Ag Novel process for the preparation of 4-aminobut-2-enolides

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ201395A (en) * 1981-07-30 1987-02-20 Bayer Ag Pharmaceutical compositions containing 1,4-dihydropyridines and certain of these dihydropyridines
DE3269219D1 (en) * 1981-11-17 1986-03-27 Fisons Plc Dihydropyridines, methods for their production and their formulation and use as pharmaceuticals
DE3315805A1 (de) * 1983-04-30 1984-11-08 Bayer Ag, 5090 Leverkusen Wirkstoffzubereitungen
DE3339861A1 (de) * 1983-11-04 1985-05-15 Bayer Ag, 5090 Leverkusen Arzneizubereitung enthaltend dihydropyridine

Also Published As

Publication number Publication date
CA1211109A (en) 1986-09-09
KR920001137B1 (ko) 1992-02-06
DK158950B (da) 1990-08-06
ES552280A0 (es) 1987-09-01
ES552277A0 (es) 1987-09-01
EP0123095A2 (de) 1984-10-31
EP0123095A3 (en) 1986-12-03
IL71314A0 (en) 1984-06-29
ES530800A0 (es) 1984-11-01
ES8707952A1 (es) 1987-09-01
NO160659B (no) 1989-02-06
GR81924B (fi) 1984-12-12
ES552278A0 (es) 1987-09-01
FI81100B (fi) 1990-05-31
DK144984A (da) 1984-09-26
IL71314A (en) 1988-12-30
US4555512A (en) 1985-11-26
ATE38229T1 (de) 1988-11-15
ES552279A0 (es) 1987-09-01
ES8707959A1 (es) 1987-09-01
NZ207588A (en) 1986-05-09
PH20322A (en) 1986-11-25
NO840950L (no) 1984-09-26
PT78311B (de) 1986-04-30
DE3311003A1 (de) 1984-09-27
NO160659C (no) 1989-05-16
FI81100C (fi) 1990-09-10
ZA842166B (en) 1984-10-31
ES8607307A1 (es) 1986-06-16
JPS59193887A (ja) 1984-11-02
FI841153A (fi) 1984-09-26
IE57039B1 (en) 1992-03-25
EP0123095B1 (de) 1988-10-26
JPH0316955B2 (fi) 1991-03-06
DE3474824D1 (en) 1988-12-01
AU2609984A (en) 1984-09-27
KR840008363A (ko) 1984-12-14
PT78311A (de) 1984-04-01
AU564838B2 (en) 1987-08-27
HU189849B (en) 1986-08-28
DK158950C (da) 1990-12-31
IE840716L (en) 1984-09-25
ES8707957A1 (es) 1987-09-01
DK144984D0 (da) 1984-02-29
ES8707958A1 (es) 1987-09-01

Similar Documents

Publication Publication Date Title
FI841154A (fi) Kromon- och tiokromonsubstituerade 1,4- dihydropyridinderivat, flera foerfaranden foer deras framstaellning och deras anvaendning i laekemedel.
FI841153A (fi) Med kromon och tiokromon substituerade 1,4-dihydropyridinlaktoner, flera foerfaranden foer framstaellning av dessa och deras anvaendning i laekemedel.
ATE24899T1 (de) Verfahren zur herstellung von 4-quinolinonen.

Legal Events

Date Code Title Description
MM Patent lapsed
MM Patent lapsed

Owner name: BAYER AKTIENGESELLSCHAFT